Buscar
Estás en modo de exploración. debe iniciar sesión para usar MEMORY

   Inicia sesión para empezar

BORDETELLA, HAEMOPHILLUS AND BRUCELLA


🇬🇧
In Inglés
Creado:


Public
Creado por:
Sage


0 / 5  (0 calificaciones)



» To start learning, click login

1 / 25

[Front]


what is the name and causative agent of a disease first decribed by Bordet et al. in 1900, a disease that causes violent paroxysmal productive cough in children.
[Back]


whooping cough, caused by Bordetella pertussis

Practique preguntas conocidas

Manténgase al día con sus preguntas pendientes

Completa 5 preguntas para habilitar la práctica

Exámenes

Examen: pon a prueba tus habilidades

Pon a prueba tus habilidades en el modo de examen

Aprenda nuevas preguntas

Modos dinámicos

InteligenteMezcla inteligente de todos los modos
PersonalizadoUtilice la configuración para ponderar los modos dinámicos

Modo manual [beta]

Seleccione sus propios tipos de preguntas y respuestas
Modos específicos

Aprende con fichas
Completa la oración
Escuchar y deletrearOrtografía: escribe lo que escuchas
elección múltipleModo de elección múltiple
Expresión oralResponde con voz
Expresión oral y comprensión auditivaPractica la pronunciación
EscrituraModo de solo escritura

BORDETELLA, HAEMOPHILLUS AND BRUCELLA - Marcador

0 usuarios han completado este curso. ¡sé el primero!

Ningún usuario ha jugado este curso todavía, sé el primero


BORDETELLA, HAEMOPHILLUS AND BRUCELLA - Detalles

Niveles:

Preguntas:

40 preguntas
🇬🇧🇬🇧
The incubation period and site of infection for B. petussi is
7-10 days, it infects the cilia of respiratory epithelium of infected children.
Transmission of whooping cough is by
Direct or droplet contact with naso[pharygeal secretion of an infected person.
The infection of whooping cough has 2 infection periods
1) from predrome- 3wks after paroxysmal cough 2) 5 days after starting antibiotic treatment( what is the antibiotic treatment?)
What is the reservoir of bordetella pertussis
Humans. there are no animal or insect vectors known. whooping cough is a child-hood infection
The virulence factors of B. pertussis include
1) adhesins: filamentous heagglutinin(FHA) rbc agglutination, and fimbriae/pilli for adherence 2) toxins which include: pertusis toxin, adnylate cyclase toxin/hemolysin, tracheal cytotoxins and lethal toxins( dermonercrotic toxins)
The epidemiology of whooping cough
Most severe in infants under 1 yr old. more than half of infant that get it will be hospitalised and some even die. in adults the disease is less severe and my not be recognised, althought infected adults can spread to infants.
Clinical symptoms of pertussis
1) catherrhal stage:first stage. lasts for 1-2 wks most infective stage. runny nose, nasal congestion, sneezing occassional cough, low grade fever. 2) paroxysmal stage: 2nd stage classical whooping cough and inspirational whoops, more at night where an average of 15 attacks in 24hrs. lasts for 1-6wks 3) convalescent stage: 3rd stage. cough with many complications: secondary bacterial pneumonia sub-conjugal hemorrhage, convulsions. lasts for weeks or months
Lab diagnosis.
1)culture: naso-pahrygeal swab is most convenient. there is also a cough plate of bordet-gengou media where patient coughs directly into. 2)fbc show leukocytosis, with ablolute lymphocytosis of 70-80% 3) DIT: serology withe ELISA and Indirect hemagglutination test. 4) PCR
What does whooping cough look like on culture media
Greyish, smooth, opaque white refractile colonies resembling pearls or mercury droplets.
Identification of B. pertussis
Gram neg coccobaccilli, non motile and non sporeforming. oxidase and catalase pos. nitrate and urea negative
Treatment
Erythromycin makes illness less contagious, give early to reduce symptoms. tetracycline, chloraphenicol and ampicillin
Further measures to prevent spread of whooping cough
Vaccination with DTP and persons with close contact should be treated with erythromycin
The haemophilus species have 3 subgroups that are of clinical improtance, what are they
1)H. influezae: causes meningitis, otitis media, cellulitis, pneuonia, epiglottitis and bronchitis 2)H. ducreyi: soft sore or chancroid 3)H aegyptius: conjunctivitis
The blood loving organism requires which factors to grow
Factor X and V which are available on chocolate agar.
Microscoptic features of H. influenzeA
Gram neg coccobaccili: non sporin non motile. some starins posses polysaccharide capsule. 6 strains. a,b,c,d,e and f. strain b (Hib) causes 95% of invasive disease
Mode of transmission
Droplets discharge from upper resp tract. most common portal of entry is nasopharynx.
Infectious period
As long as organism is present. non infectious within 24-48 hrs after start of antibiotics
Reserviours
Humans. children and adults are carriers
Virulence factors of H influenzae
1) capsular polusaccharide 2) lipopolysaccharide 3)IgA protease 4)pili
Clinical presentationof H. influenzae
1)meningitis: fever, headaches, stiffneck, photophobia, seizures and coma in infants, poor feeding and bulging fontanelle in chidren 2mths-2 years: mortality and neurological complications are high. 2) epiglottis: second most common infection of H. influenzae in children 3-18months. sudden onset sore throat and fever, shortness of breath, obstructied airways, difficulty to swallow. life threatening 3) pnemonia 4) celluitis 5) septic arthritis.
Specimen for lab diagnosis of H. influenzae
Specimen: csf and blood, nasopharyngeal swab, pus, sputum, aspirate from join and throat swab
Lab diagnosis of H. influenzae
1)gram stain and culture on chocalte agar for factor X and V. satellitism with stap aureus. 2)capsular detection by quellung rxn or latex agglut. test. 3)slide agglut. test.
Lab identification of H. influenzae
Gram neg coccobacilli. require factor X and V from chocolate agar. presence of 5-10% cO2 to enhance growth. cannot grow on nutrient agar. catalase and oxidase pos. satellitsim for S. aurus which acts as a source of factor V(NADP co enzyme) FActor X is found in blood.
Treatment of H. influnzae
1) sulphonaides: trimethoprim-sulphamethoxazole 2) chloramphenicol 3) ciprofloxacin 4)ampicillin 5) cefotaxime 6) ceftazidime
Preventation and control of H. influnzae
PRP vaccine, conjugate PRP antibiotic chomoprophylaxis with rifampin.
Virulence factor of H, ducreyi
Pilli, outer embrane protien
Microscopic characteristics of H ducreyi
Gram negative coccobaccili: shows bipolar staining. occurs in parrallel chains "school fish r rail road track" grow on CAM- chorioallantonic membrane of live chick embryo grow on chacolate agar with factor X but not V
Treatment of H ducreyi
Azithromycin, ceftrixone, cipro and tetracyclin
H. aegyptius causes highly infectious form of acute conjunctivitis, what are its microscopic characteristics?
Gram negative bacillus: requires the same growth factor as H. influenzae( factor X and V on chocolate agar). thus sometimes called H. influeza biotypeIII.
Incubation period of Brucela sp
5days-several weeks. presents an undulating fever pattern.
Various sp of brucella include
B. abortus: cattle and buffalomost important cause of human brucellosis in Uk B melitensis: sheep and goat: malta and mediterranean fever and potentia agent for bio terrorism. B Suis : pigs: common in swine rearing areas in US. B. Canis: dog: common in dog handlers.Treat with Minocycline and streptomycin.
Virulence factors of Brucella
Lippopolysaccharide.
Clinical presentation of Brucella infection
Acute infection is non specific and chronic infection in incompletely treated patients. duration of illness: weeks- months.
Lab diagnosis
Blood culture: serolgicall: four-fold rise in titre and 1:640 or more i acute disease. ELISA in animal: atibody in milk by milk ring test and rose bengal test.
Treatment
Gold standard: doxycycline plus streptomycin gentamycin for 3-4 wks doxycycline plus rifapin for 4-6wks rifampin plus cipro: who therapy. relapse is common on therapy with singe dose.
Primary prevention
Minimal exposure and pasturisation of dairy product. vaccinatio for animals. no vaccine for humans.